メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
富山大学 ホーム
日本語
English
ホーム
プロファイル
研究部門
プロジェクト
研究成果
データセット
受賞
活動
コース
専門知識、名前、または所属機関で検索
Neural basis for the ability of atypical antipsychotic drugs to improve cognition in schizophrenia
Tomiki Sumiyoshi
*
,
Yuko Higuchi
, Takashi Uehara
*
この論文の責任著者
神経精神医学講座
研究成果
:
ジャーナルへの寄稿
›
学術論文
›
査読
65
被引用数 (Scopus)
概要
フィンガープリント
フィンガープリント
「Neural basis for the ability of atypical antipsychotic drugs to improve cognition in schizophrenia」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Schizophrenia
100%
Neural Basis
100%
Atypical Antipsychotics
100%
Cognitive Impairment
66%
Functional Outcome
66%
5-HT1A Receptor
66%
5-HT1A Agonist
66%
Event-related Potentials
33%
Stress-induced
33%
Energy Metabolism
33%
Dopamine
33%
Patients with Schizophrenia
33%
Neural Network
33%
Recent Advances
33%
Psychosis
33%
Cognitive Deficits
33%
Novel Therapeutics
33%
Chronic Treatment
33%
Rat Model
33%
Glutamate
33%
Prefrontal Cortex
33%
γ-aminobutyric Acid
33%
Lactate
33%
Facilitative Effects
33%
Mood Disorders
33%
Risperidone
33%
Schizophrenia Models
33%
Clozapine
33%
Olanzapine
33%
Clinical Evidence
33%
Cognitive Enhancement
33%
Perospirone
33%
Tandospirone
33%
Lactate Production
33%
Blonanserin
33%
Electrophysiological Measures
33%
Lurasidone
33%
Psychotic Illness
33%
People with Schizophrenia
33%
5-HT Receptor Subtypes
33%
Quetiapine
33%
Serotonin (5-HT) Receptors
33%
Melperone
33%
Neuroscience
Cognitive Disorders
100%
Typical Antipsychotic
100%
Atypical Antipsychotic
100%
5-HT1A Receptor
66%
5-HT Receptor
66%
5-HT1A Agonists
66%
Serotonin
33%
Event-Related Potential
33%
Prefrontal Cortex
33%
Receptor Subtype
33%
Energy Metabolism
33%
Gamma-Aminobutyric Acid
33%
Glutamic Acid
33%
Mood Disorder
33%
Clozapine
33%
Neural Network
33%
Risperidone
33%
Olanzapine
33%
Psychoactive Drug
33%
Melperone
33%
Lurasidone
33%
Tandospirone
33%
Quetiapine
33%
Receptor
33%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Atypical Antipsychotics
100%
Cognitive Defect
75%
Lactic Acid
50%
Serotonin 1A Agonist
50%
Disease
25%
Receptor Subtype
25%
4 Aminobutyric Acid
25%
Rat Model
25%
Glutamic Acid
25%
Serotonin
25%
Psychotropic Agent
25%
Olanzapine
25%
Risperidone
25%
Miconazole
25%
Clozapine
25%
Tandospirone
25%
Melperone
25%
Blonanserin
25%
Mood Disorder
25%
Lurasidone
25%
Perospirone
25%
Quetiapine
25%